TRIM28 and β-actin identified via nanobody-based reverse proteomics approach as possible human glioblastoma biomarkers
通过基于纳米抗体的反向蛋白质组学方法鉴定出 TRIM28 和 β-actin 可能是人类胶质母细胞瘤的生物标志物
期刊:PLoS One
影响因子:2.9
doi:10.1371/journal.pone.0113688
Ivana Jovčevska, Neja Zupanec, Nina Kočevar, Daniela Cesselli, Neža Podergajs, Clara Limbaeck Stokin, Michael P Myers, Serge Muyldermans, Gholamreza Hassanzadeh Ghassabeh, Helena Motaln, Maria Elisabetta Ruaro, Evgenia Bourkoula, Tamara Lah Turnšek, Radovan Komel